Sunday, November 7, 2010

Journals: Withdrawal Effect in Myocardium


CoQ10 Long-Term Supplementation
May Result in Withdrawal Effect in Myocardium
Author: Kalenikova, E;   Pp.13.492
Lomonosov Moscow State University, Faculty of Basic Medicine,
Department of Pharmacology, Moscow, Russia
Cardiology Research Center, Moscow, Russia

Abstract
Objective: Coenzyme Q10 (CoQ10) is used as cardioprotector. CoQ10 is endogenous substance and long-term administration of exogenous CoQ10 can influence on its tissue biosynthesis. The aim of the study was to examine the possibility of replenishment of coenzymes Q myocardial level by long-term supplementation with solubilized CoQ10 and to estimate myocardial CoQ content after discontinuation of supplementation.


Design and Methods: Male conscious Wistar rats (n = 30) were supplemented with solubilized CoQ10 (10 mg/kg/day per os; Kudesan solution, “Akvion”, Russia). Serum and myocardial levels of CoQ9, CoQ10 were measured after 3 weeks (n = 6), 6 weeks (n = 8) of administration and 2 weeks (n = 8), 6 weeks (n = 8) after discontinuation. Tissue samples were collected 3–4 h after the last administration. Age-matched rats served as control. Myocardial levels of CoQ were estimated in supernatants of homogenates. Assay carried out using HPLC with electrochemical detection after liquid extraction with ethanol-hexane mixture. Statistical analysis was performed with two-tailed t-test.
Results: Serum CoQ10 level after 3 and 6 weeks of supplementation was 10 time higher than in control rats. 2 weeks after discontinuation serum CoQ10 level was 3 time higher than in control group and 6 weeks after discontinuation CoQ10 level was not different from control values. CoQ9 serum concentration did not differ between groups. Myocardial content of CoQ10 increased by 40% and 60%, CoQ9 – by 75% and 50% after 3 and 6 weeks of treatment, correspondently. Discontinuation of CoQ10 supplementation evoked the fall of CoQ9 (by 50%) and CoQ10 (by 60%) levels below the control values in 2 weeks; recovery to the control levels was detected in 6 weeks.
Conclusion: Results demonstrate CoQ10 withdrawal effect in rat myocardium. These data have to take account of long-term treatment the patients with cardiovascular diseases.

Monday, October 11, 2010

Journals: Neurodegenerative Disease


Coenzyme Q10 effects in neurodegenerative disease
Authors: Meredith Spindler, M Flint Beal, Claire Henchcliffe
Published Date November 2009 , Volume 2009:5 Pages 597 - 610 DOI 10.2147/NDT.S5212
Meredith Spindler, M Flint Beal, Claire Henchcliffe
Department of Neurology, 2Department of Neuroscience, Weill Medical College of Cornell University, New York, NY, USA


Coenzyme Q10 (CoQ10) is an essential co-factor in the mitochondrial respiratory chain, and as a dietary supplement it has recently gained attention for its potential role in the treatment of neurodegenerative disease. Evidence for mitochondrial dysfunction in neurodegenerative disorders derives from animal models, studies of mitochondria from patients, identification of genetic defects in patients with neurodegenerative disease, and measurements of markers of oxidative stress.

Studies of in vitro models of neuronal toxicity and animal models of neurodegenerative disorders have demonstrated potential neuroprotective effects of CoQ10. With this data in mind, several clinical trials of CoQ10 have been performed in Parkinson’s disease and atypical Parkinson’s syndromes, Huntington’s disease, Alzheimer disease, Friedreich’s ataxia, and amyotrophic lateral sclerosis, with equivocal findings.

CoQ10 is widely available in multiple formulations and is very well tolerated with minimal adverse effects, making it an attractive potential therapy. Phase III trials of high-dose CoQ10 in large sample sizes are needed to further ascertain the effects of CoQ10 in neurodegenerative diseases.



Sunday, September 19, 2010

Vice Binoy Lajara

Avid user, Vice-Major Severino "Binoy" Lajara expresses his satisfaction to our product as he joins the people behind endorsing McVil CoQ10. He goes "I have been looking for this kind of quality product since my doctor in Makati Medical Center prescribed me together with my statin drugs"

Nearly two months using the product, the naturally likable politician, boasts his daily consumption of this "wonder nutrient" with his fellow Calambenos --- "Pampabata at pampalakas ng puso, rekomendado ng doktor ko!"


                                                                                           
 

Monday, September 13, 2010

Batangas Visit / Gov. Vilma Santos' Office



Deretsahan hosts and Mcvil Global's - Mcvil CoQ10 has visited Batangas Province and to Gov. Vilma Santos's office to promote the "wonder nutrient". Setting up a new date, the company is looking forward for the availability of the product in the whole province before end of this year.

Mcvil Global is also hoping that the support of the local government will finally be pushed through especially with programs like Gov. Vilma Santos' H.E.A.R.T.S. program and associating it to the brand's tag line "Protecting your heart is no longer an option..."

The H.E.A.R.T.S. program is carved from the cultural tradition of the Batanguenos and promoting its province through tourism and empowering its citizens. Please check Batangas H.E.A.R.T.S. program direct link:

Friday, August 27, 2010

Japan and its Coenzyme Q10 Market

Japan Dominates the Coenzyme Market

Coenzyme Q10 was first developed and produced in Japan as a medical product for treating heart failure. However, the substance first came into widespread use not in Japan but in the United States and Europe, where it has been used as an ingredient in foods and cosmetics since the 1990s. The Coenzyme Q10 boom has come to Japanese shores late in the game. But when it comes to coenzyme production, Japanese manufacturers have a virtual monopoly. And they have made an array of innovations that have helped popularize Coenzyme Q10.

In October 2004, Coenzyme Q10 was approved for use in cosmetics as well as foods. Shiseido Co., Kao Corporation, and other leading cosmetic makers have responded by introducing a slew of skin-care products featuring the coenzyme. Consumers are eagerly snapping up lotions and other skin-care items claiming to offer anti-aging benefits.

Wednesday, August 25, 2010

Deretsahan Aug. 23, 2010




DZJV's deretsahan august 23, 2010 

as posted in www.ustream.tv


Tuesday, August 24, 2010

Disastrous Side Effects from Statins

Disastrous Side Effects from Statins:article posted in the Davidson Family Chiropractic
June 17th, 2010
http://maxhealthradio.com/tag/coenzyme-q10/

Doctors and patients are being warned again about the dangers of cholesterol lowering medications (also known as statins).  After analyzing data from more than 2 million people in a six year period, new research shows that cholesterol lowering medications cause even more side effects.  The British Medical Journal May 20, 2010 provided the following list of new side effects from statins: liver problems, acute kidney failure, muscle weakness and cataracts.

A paper published in the American Journal of Cardiovascular Drugs 2008;8(6):373-418 provides citations of 900 studies that show the adverse side effects associated with statin medications.  One of the best known are muscle problems, but also included in that list are the following: elevated blood glucose (diabetes), tendon problems (muscles detaching from bone), cognitive problems (Parkinson’s and Alzheimer’s disease) and pain or numbness in the arms and legs (carpal tunnel & sciatica).

Most side effects do not show up immediately from the medication.  When taking these medications more long term side effects begin to show up.  Cataracts, sexual dysfunction, acidosis, anemia, frequent fevers, increase cancer risk, immune system suppression, severe degenerative muscle tissue condition (rhabdomyolysis), pancreatic dysfunction and hepatic dysfunction.
Probably the scariest thing about Cholesterol medications is the warning label on them that states that this medication has been proven to lower overall cholesterol, but has NOT been proven to prevent heart attacks or prevent early death.  Translation, you will not live longer, you will just die with a lower cholesterol!

If you are on statins, you must take the supplement CoQ10.  CoQ10 (Coenzyme Q10) is depleted from statin medications.  The depletion has be linked with impaired cardiac function, which translates to heart problems, loss of cell energy, increased production of free radicals and mitochondrial DNA damage.  High blood pressure and diabetes are linked to higher rates of mitochondrial problems, which means that the risk of statin complications are even higher!
Leading experts say that total cholesterol will tell you virtually nothing about your risk of heart disease unless it is 330 or higher.  It is important to understand that cholesterol is not the cause of heart disease.
If you become overly concerned with trying to lower your cholesterol level to some set number, you will be completely missing the point.

Important heart disease markers
HDL percentage is a very potent heart disease risk factor. Just divide your HDL level by your cholesterol. That percentage should ideally be above 24 percent. Below 10 percent, it’s a significant indicator of risk for heart disease.  You can also do the same thing with your triglycerides and HDL ratio. That percentage should be below 2.  A highly sensitive C-reactive protein (hs-CRP) assay to detect hidden inflammation.  According to American Heart Association, hs-CRP levels lower than 1.0 mg/L are good; hs-CRP levels higher than 3.0 mg/L are cause for concern.

Japan Coenzyme Q Association Approved 10 Products

as posted: 
Japan’s Nutraceuticals Today - CoQ10, GMP and FOSHU Update
http://www.npicenter.com/anm/templates/newsATemp.aspx?articleid=14032&zoneid=45


The Japan Coenzyme Q Association (www.coenzymeq-jp.com) (JCQA) has approved 10 products from 7 companies which meet the organization’s standard for safety, quality and other specifications. JCQA has been a sister organization of the International Coenzyme Q 10 Association (Wayne, PA) since November 2002. In June 2005, JCQA started a program of CoQ10 certification and this is their first group of products to comply with their standards. Products must be produced from GMP- or ISO-approved factories and must contain a minimum of 30mg of CoQ10 in a capsule or a tablet. Approved products are not limited to dietary supplements but can also be for food and beverages applications. One of the approved products this particular time was a beverage from Coca Cola Japan, (www.cocacola.co.jp) called Coca Cola Coenzyme Q10. It contains 60mg of CoQ10, L-Carnitine and vitamin C. 


JCQA issues its logo for use on approved products to organizations who comply with their standards.


Two Organizations Spearhead a GMP Certification Program


JHNFA (Japan Health Food & Nutrition Food Association) and a newly formed Japanese Institute for Health Food Standards (JIHFS) (www.jihfs.com) have founded a GMP (Good Manufacturing Practices) certification program. The GMP for health foods and dietary supplements were adapted from drug manufacturing safety standards to meet MHLW’s FOSHU (Foods for Specified Health Uses) manufacturing standards. They are not a requirement for non-FOSHU products manufacturers yet, but increasing creditability and developing a competitive manufacturing environment (especially among contract manufacturers) will eventually lead to implementation of GMP into non-FOSHU manufacturers’ plants.


Both programs are based upon third party inspections and the organization’s own audits and evaluation of their respective GMP programs. So far, JHNFA has approved 3 plants and JIHFA has approved one. JIHFS allows its JIHFS GMP logo to be used on products made by approved manufacturers.

ConsumerLab.Com Article

As posted in Consumerlab.com:
http://www.consumerlab.com/news/Japanese_Supplements_Tests_CoQ10/5_10_2005/

CONSUMERLAB.COM BEGINS PUBLISHING TEST REPORTS ON JAPANESE VITAMINS AND SUPPLEMENTS
— Review of CoQ10 Products Now Available Online in Japanese at ConsumerLab.jp. More Reports Scheduled —
 
WHITE PLAINS, NY — MAY 10, 2005 — ConsumerLab.com announced today the release of its first report on the quality of supplements in Japan. This begins an ongoing series of reports for Japanese consumers on ConsumerLab.com's new Japanese language website www.consumerlab.jp. ConsumerLab.com has published similar reports for U.S. and Canadian consumers since 1999 at www.consumerlab.com — a popular site that receives over 2 million visits annually.

The first report provides test results for coenzyme Q10 (CoQ10) supplements purchased in Japan. CoQ10 is a top selling supplement in Japan, popularized in 2004 in television reports. One of the products was found to contain only 56% of its claimed amount of this expensive ingredient. Such a discrepancy represents both an economic loss to consumers and is of medical concern since CoQ10 has demonstrated potential in the treatment of tightly controlled conditions such as congestive heart failure, Parkinson's disease, hypertension, and AIDS (HIV). Eleven other products contained their clamed amounts of CoQ10. 

"If a person was to switch between a brand with 100% of its CoQ10 to one with only half its stated amount or vice versa, their condition may change but it is unlikely that they or their doctors would know the true reason," said Tod Cooperman, M.D., President of ConsumerLab.com. Dr. Cooperman urged people to use CoQ10 products that have been independently tested.

In both 2000 and again in 2004, ConsumerLab.com has reported finding problems with some CoQ10 products sold in the U.S — most notably one product with no detectable CoQ10 and another with only 17% of its claimed amount. Earlier this year, the Japan Ministry of Health reported finding a CoQ10 product to contain no CoQ10, but a different compound, idebenone, which looks similar to CoQ10. Consequently, ConsumerLab.com checked for idebenone in the product that it found to be low in CoQ10, but idebenone was not present. 

ConsumerLab.com selected ten of the products reviewed. Two additional products, from Yerba Prima (distributed by Japan Whole Foods) and PillBox Japan, are included in the Review for having passed the same testing through ConsumerLab.com's Voluntary Certification Program. The report identifies the eleven products that passed testing. The product that failed is not identified. ConsumerLab.com is notifying the manufacturer of the failed product of the problem with the hope that corrective action will be taken. ConsumerLab.com remains willing to test new and reformulated CoQ10 products through its voluntary program. If such products pass testing, they will be added to the report. 

The report is found at http://www.consumerlab.jp/ja-JP/results/CoQ10.asp. A summary of the report is available for free. Subscription is required for the full report, which also includes expert information on how to buy and use CoQ10. Subscription is $9 (approximately ¥950) for the report or $24 (approximately ¥2,500) for 12 months of reports online. Results of the study will also be discussed in a presentation at Natural Products Expo Japan taking place on May 17th at the Tokyo Ryutsu Center.

Tests of many other types of Japanese supplements are in progress. A Product Review of Ginseng Supplements, including popular ginseng-containing drinks, will be released in coming weeks. Reports on twenty to thirty other categories of supplements will be released every four to six weeks, with Reviews of Alpha Lipoic Acid, Ginkgo Biloba, and Multivitamins due in coming months. The www.consumerlab.jp website also allows consumers to view product prices from Japanese vendors, such as Kenko.com. ConsumerLab.com does not receive revenue from product sales. The Japanese website also links to ConsumerLab.com's English-language site, allowing Japanese visitors to check results for U.S. and Canadian products.

ConsumerLab.com is a leading provider of consumer information and independent evaluations of products that affect health and nutrition. The company is privately held and based in New York, U.S.A. It has no ownership from, or interest in, companies that manufacture, distribute, or sell consumer products. Subscription to ConsumerLab.com is available online. For group subscriptions or voluntary product testing contact Elena Yoo, Japan Manager at Elena.Yoo@ConsumerLab.com.

What Else Can Coenzyme Q10 Do for us?

As Coenzyme Q10 is involved in metabolic production of ATP, it also has a large role in the metabolism of fat. Actually, Coenzyme Q10 stimulates the body’s metabolism, and thus has a good effect on losing weight and fat burning.

Additionally, as CoQ10 is also crucial in electron transport, it is a powerful anti-oxidant. Anti-oxidants are those chemicals that help free the body of free radicals (that often lead to cancer).

Lastly, Coenzyme Q10 levels have been positively linked to healthy hearts. The opposite is true, that unhealthy hearts almost always have a deficiency of Coenzyme Q10.

Are you Coenzyme Q10 Deficient?

If you are eating well, but not losing weight; if you are working out but seem to have no energy after a few minutes; if you are over 30; if your immune system seems weaker than it should be, chances are you are Coenzyme Q10 deficient.

Today’s food additive Coenzyme Q10 is basically of very high purity and quality, made from natural sources, and available in doses from 75mg to 150mg.

If you suffer from any of the conditions above, you might benefit greatly by including some Coenzyme Q10 in your diet (as a food supplement). You might choose a soft gel capsule rather than a hard tablet, as it is absorbed much faster.

Also, if you taking Coenzyme Q10 for heart reasons, ask your doctor about higher doses. I Use Statins – Can I take Coenzyme Q10?

Statins are the main ingredient in many cholesterol reducing medicines. They are also one of the most prescribed medications today. Researchers believe that statins can inhibit Coenzyme Q10 production in our bodies. If this is so, we need to take this supplement more than we had previously thought.

If you are a statin taker, you must discuss with your doctor the possibility of taking Coenzyme Q10 at the same time.

Sunday, August 8, 2010

Tuesday, July 6, 2010

Clinical Trial of High Dose CoQ10 in ALS

CoQ10 in ALS:


http://clinicaltrials.gov/ct2/show/record/NCT00243932

Uses and Efficacy/ Contra Indication


Coenzyme Q10’s wide-ranging cellular properties implicate it for the potential treatment of numerous conditions that may improve with mitochondrial and antioxidant support.

NEUROLOGIC AND METABOLIC INDICATIONS

Parkinson’s Disease
A randomized, double-blind, placebo-controlled, multicenter study of 80 patients found that 1,200 mg per day of coenzyme Q10 was associated with up to 44 percent less functional decline in patients with Parkinson’s disease, including activities of daily living. A study of 28 patients with Parkinson’s disease also demonstrated mild symptom improvement with daily oral dosing of 360 mg of coenzyme Q10. These results are awaiting confirmation.

Mitochondrial Encephalomyopathies
In studies with eight to 44 patients, coenzyme Q10 also has demonstrated positive trends in reducing symptoms associated with selected mitochondrial abnormalities including the mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome, Kearns-Sayre syndrome, and the myoclonus epilepsy with ragged-red fibers (MERRhF) syndrome. Maximum effect often requires six or more months of therapy. One type of coenzyme Q10, UbiQGel, was granted U.S. Food and Drug Administration (FDA) orphan drug status for treatment of mitochondrial cytopathies based on several small trials. 

Migraine
A preliminary open label trial of 32 patients taking 150 mg of coenzyme Q10 daily demonstrated efficacy in reducing the frequency of migraine attacks. A recent randomized double-blind, placebo-controlled trial of 42 patients taking coenzyme Q10 at 300 mg a day found similar benefit. The response rate (i.e., decrease in headache frequency by 50 percent or more) was 47.6 percent in the coenzyme Q10 group and 14.4 percent in the placebo group. The number needed to treat was three.

Other Neurologic Indications
Coenzyme Q10 at 600 mg or less did not delay progression of decline in functional ability in Huntington’s disease, but it also has FDA orphan drug status for this disease.


CARDIOVASCULAR INDICATIONS

CHF
A number of randomized controlled trials, including those in a 1997 meta-analysis, found improvement in several clinical parameters related to CHF, including frequency of hospitalization, dyspnea, and edema. These trials were weakened by small numbers (only two of 14 trials had more than 25 participants) and older techniques for calculating ejection fraction. Of the more recent randomized trials using ventriculography and echocardiography, two found coenzyme Q10 at 100 to 200 mg daily no more effective than placebo in improving ejection fraction, peak oxygen consumption, exercise duration, or quality of life. A more recent trial using coenzyme Q10 in combination with carnitine and taurine did find modest clinical improvement. The recently released Agency for Healthcare Research and Quality (AHRQ) report that examined cardiovascular trials with more than 60 participants followed for at least six months concluded that coenzyme Q10’s role is still an open question. The planned SYMptoms, BIomarker status (BNP), and long-term Outcome trial with more than 500 patients with New York Heart Association class III and IV CHF followed over two years, should help answer this question. 

Hypertension
A systematic review of eight trials using coenzyme Q10 at various doses for essential hypertension, typically as adjuvant therapy, found a mean decrease in systolic and diastolic blood pressure of 16 and 10 mm Hg, respectively. Several of these trials demonstrated confounding variables or were weakened by low statistical power.

Other Indications
The evidence for coenzyme Q10 use in other cardiovascular settings is promising and requires larger, longer-term trials. In placebo-controlled trials, the coenzyme’s use following cardiopulmonary resuscitation demonstrated improvement in three-month survival (n = 49), and its use following cardiac surgery demonstrated improvements in myocardial isoenzyme levels, left ventricular function, and postoperative recovery time (n = 20). 

Preliminary data also imply benefit in the setting of atherosclerosis. This includes a randomized, placebo-controlled trial of 73 patients who were randomized to 120 mg a day of coenzyme Q10 following myocardial infarction. At one year, the coenzyme Q10 group demonstrated a significant decrease in total cardiac events including nonfatal myocardial infarctions and cardiac deaths. This improvement has been attributed to possible attenuation of endothelial dysfunction. Research in other conditions, including angina pectoris, cardiomyopathy and physical exercise capacity, demonstrate conflicting results and require additional study.

DIABETES
Coenzyme Q10 has been considered for improving glycemic control through various mechanisms, including a decrease in oxidative stress. Two earlier randomized controlled trails using 100 to 200 mg of coenzyme Q10 in patients with type 1 or 2 diabetes found no difference in glycemic control and insulin requirement. A more recent randomized controlled trial (n = 74) using 200 mg per day for 12 weeks found modest improvements in A1C levels (−0.37 ± 0.17 percent,P = .32).

OTHER INDICATIONS
Although it is used for the prevention and treatment of cancer, the AHRQ found no evidence to assess the efficacy of coenzyme Q10 for this use. Research continues with several phase II trials underway to clarify its potential contribution in the treatment of conditions, such as Duchenne’s muscular dystrophy, breast cancer, human immunodeficiency virus and acquired immunodeficiency syndrome, periodontal disease, and Alzheimer’s disease.

Contraindications, Adverse Effects, and Interactions

No absolute contraindications are known for coenzyme Q10, although reliable information about its use in pregnant or breastfeeding mothers or in young children is not available. Adverse effects with coenzyme Q10 are rare. On average, mild gastrointestinal discomfort is reported in less than 1 percent of patients in clinical trials. Potential interactions with warfarin (Coumadin) causing decreased international normalized ratio (INR) have been reported in case studies. However, a prospective placebo-controlled trial of 24 stable patients taking warfarin and 100 mg of coenzyme Q10 over four weeks found no significant change in prothrombin time and INR levels. Because of coenzyme Q10’s potential hypoglycemic and hypotensive effects, monitoring is advised, especially when using adjunctively with prescription medications.
Several trials demonstrate coenzyme Q10 depletion subsequent to statin initiation. There is conjecture about this depletion as the cause of statin–associated adverse effects (e.g., myopathy) with exogenous coenzyme Q10 supplementation as a possible mediating treatment. This assertion is refuted by a more recent crossover trial that found no significant coenzyme Q10 drop after initiation of selected statins. Several doxorubicin (Adriamycin) trials, mostly in animal models, have noted a reduction in cardiac coenzyme Q10 depletion and cardiotoxicity associated with coadministration of coenzyme Q10. The clinical implications on disease state and adverse reaction profile with coenzyme Q10 supplementation in depleted states requires further evaluation.

General Description of CoQ10


GENERAL DESCRIPTION:

Coenzyme Q10 (CoQ10) was discovered by scientists at the University of Wisconsin in 1957. It is also known as ubiquinone, from the word ubiquitous meaning "everywhere". CoQ10 is a powerful antioxidant found in every cell of the body, where it has important functions within the mitochondria - the "powerhouses" of cells.


ROLE FOR ANTI-AGING:

CoQ10 is popular as a supplementary treatment for several heart conditions in Europe, Israel, and Japan. Researchers believe that CoQ10 aids the heart during times of stress, possibly by helping it to use energy in a more efficient manner. It is most commonly used for congestive heart failure (CHF), however research has showed that it may be of benefit in other illnesses, including AIDS, angina, cancer, diabetes, male infertility, muscular dystrophy, obesity, and Parkinson’s disease. However there is no clinical proof of its effectiveness in treating these conditions. CoQ10 is also known to help prevent aging of the skin, and is a common ingredient in many moisturizers.


DEFICIENCY SYMPTOMS: None known


THERAPEUTIC DAILY AMOUNT:

The recommended dosage of CoQ10 ranges from 30 to 300 mg daily, usually taken in 2-3 doses. The majority of research on CoQ10 for the treatment of heart conditions has used doses ranging between 90 and 150mg. No RDA has been established.


MAXIMUM SAFE LEVEL: Not established


SIDE EFFECTS / CONTRA-INDICATIONS:

CoQ10 can interact with many different types of drugs; therefore, anyone taking any form of medication, especially cholesterol-lowering drugs, should consult their doctor before taking CoQ10. Pregnant and breastfeeding women should check with their physician before taking CoQ10.

as posted in: www.worldhealth.net

Wednesday, June 30, 2010

Jack of all Nutrients: CoQ10

"Jack of all Nutrients": Co-enzyme Q10

CoQ10 has proved helpful in increasing energy, preventing and treating circulatory and heart problems, enhancing weight loss, boosting the immune system, and much more.

At an anti-aging conference, I heard an enthusiastic medical doctor telling a skeptical listener that coenzyme Q10 is helpful in rewing up energy, protecting the soundness of gums and teeth, preventing heart disease, coping with obesity and cancer, bolstering the immune system, and delaying the aging process.

"Is there anything coenzyme Q10 can't do?" asked the skeptic.

"About the only thing it can't do is set a VCR," laughed the speaker.

Exploring the versatility of CoQ10

The versatility CoQ10 is anything but a laughing matter. It is known by most accounts as one of the most incredible supplements on the shelves of health food stores.

Although coenzyme Q10 exists in many foods, thus earning its other name, ubiquinone, much research shows that patients with a vast spectrum of serious medical conditions are frequently CoQ10-deficient.

The harsh fact is this: too many people mainly eat "dead" (processed) foods. Coenzyme Q10 can be synthesized in the body from whole foods rich in tyrosine and phenylalanine (amino acids), vitamin E, folic acid, and vitamins B-1 and B-6, along with its brother and sister coenzymes Q1 through Q9, but not from any single nutrient.

Well, wouldn't people who eat live, fresh, whole foods be able to synthesize enough CoQ10? Some segments of the population would.

However, around middle-age, we begin to lose our ability to synthesize this nutrient from the diet. At this time, and possibly before, is when supplements come in to help.

Vegetarians, and some others, will not find acceptable most of the foods containing coenzyme Q10: beef, muscle and organ meats, including liver, egg yolk, milk fat, codfish, and sardines. However, various whole grains and wheat germ, as well as peanuts and spinach, contain some levels of this nutrient.

When most measures fail to help fatigued or exhausted people, I have determined that many find relief in taking CoQ10. As one of the biochemical fuels most needed to produce desired energy, CoQ10 seems to fire up the mitochondria, the micro-furnaces in our trillions of cells.

Growing in popularity in the United States, CoQ10 is most widely known and used outside of our borders--in Europe and, mainly, in Japan, where nearly 300 different CoQ10 products are sold. Supply can hardly keep up with demand.

CoQ10 prevents G, Nutrientum disease

The Japanese commonly take CoQ10 supplements to manage or prevent swollen gums and deterioration of bone structures supporting teeth, among other uses. Edward G. Wilkinson, D.D.S., a periodontal specialist with the United States Air Force, investigated indepth causes of serious gum diseases, and invariably found a serious deficiency in coenzyme Q10. By supplementing patients' diets with this nutrient, he was able to reverse gum disease which threatened each of them with a loss of all their teeth -- conditions considered hopeless by other dental specialists.

A frightening statistic tells us that 30 million Americans have such an advanced state of gum disease that they will lose all their teeth unless they get immediate periodontal treatment. Another reveals that 60 percent of young people suffer periodontal problems, as well as 90 percent of seniors over 65.

Heart health relies on CoQ10

Probably the most exciting use of CoQ10 is for the prevention and treatment of many types of heart and artery disorders--high blood pressure, deficient heart energy, and low-oxygen conditions threatening the integrity of heart tissue. When blood delivery is reduced because of clogged arteries or during a heart attack, CoQ10 helps. In addition, it can contribute to reducing the pain of angina and in regularizing irregular heartbeat.

Patients with congestive heart failure appear to derive great benefit from CoQ10 supplementation. Twelve such patients who failed to improve on digitalis and diuretics, traditional drugs for such a condition, showed notable improvement on 100 mg daily of CoQ10 for one month.

Until recently, the only hope for most cardiomyopathy patients was heart transplant, a hazardous and costly procedure. (This condition is characterized by exaggerated thickening of the heart muscle and obstructive damage to the heart.) Then cardiologist Per H. Langsjoen, M.D., of the Scott and White Clinic in Temple, Texas, had advanced cardiomyopathy patients try 100 mg of CoQ10 daily for 12 weeks, he noted "a remarkable clinical improvement."

In his double-blind, cross-over study of 19 patients, published in the Proceedings of the National Academy of Sciences, Langsjoen reported increased volume of blood pumped, improved heart strength, and diminished shortness of breath --all with no side effects. These benefits continued for three years.

CoQ10 normalizes blood pressure

In animal studies, CoQ10 has also been found to normalize high blood pressure; these results were verified in human studies. A Japanese researcher Toru Yamagami fed 25 patients suffering with hypertension 60 mg of CoQ10 daily for eight weeks. All participants showed a significant decrease in blood pressure. The average drop in pressure was greater than 10 percent.

A similar study by Yamagami and Karl Folkers, of the University of Texas--the latter a pioneer researcher in CoQ10--showed that hypertensive patients recorded a noteworthy drop in blood pressure after a daily intake of 35 to 45 mg of this supplement for several weeks. Many of them registered declines in pressure to normal levels.

CoQ10 protects the muscles of the heart

Animal studies show positive results after supplementation with CoQ10. In cases of myocardial infarction--death of heart tissues due to obstructed blood circulation --damaged areas were reduced in size. The myocardium--the middle muscular layer of the heart--was protected against insufficient blood flow.

"A deficiency of CoQ10 is common in cardiac patients," states The Nutrition Superbook: The Antioxidants. "When it was looked for, myocardial biopsies done on patients with various cardiac diseases showed that there was a deficiency of the coenzyme in 50 to 75 percent of the patients studied."

Weight loss enhanced with CoQ10

In addition to its hopeful, beneficial effects on cardiovascular ailments, CoQ10 has been shown to contribute to weight loss through firing up the cell mitochondria (micro-furnaces) and, therefore, increasing the burning off of accumulated fat.

Dr. Luc Van Gaal and colleagues noted in a paper, "The Exploratory Study of Coenzyme Q10 in Obesity," their results of a study of two groups of obese volunteers on the same controlled reducing diet. The only difference was that one group received 100 mg of CoQ10 daily over nine weeks, while the other group did not. Those on CoQ10 lost 30 pounds compared with l pounds for the other group.

Other benefits of this nutrient

One of the questions often asked about CoQ10 is: "It seems to help many medical conditions, but is useful for treating cancers?" Animal studies indicate that it increases resistance to virally and chemically-caused cancers by stimulating the metabolic activity in the immune system.

Dr. Emile Bliznakov, scientific director of the Lupus Research Institute in Ridgefield, Conn., discovered that CoQ10 doubles the immune system's antibody level against bacterial organisms and also offers a higher level of resistance to viruses.

Likewise, in animal experiments Bliznikov found that CoQ10 significantly increased their life span--by some 56 percent in some in stances--and, equally meaningful the animals looked and acted younger and more energetic.

Further, studies of CoQ10-deficient animals exhibited a marked deterioration of their immune system, contributing to a shorter life. One of Bliznikov's animal studies revealed that the amount of CoQ10 declines by as much as 80 percent over the course of normal aging.

The Nutrition Superbook: The Antioxidants comments on this finding

"A decline of this magnitude in a human being would be fatal, but deficiencies approaching this have been observed in aged humans and are associated with grave heart disease."


REFERENCES:

Barilla, Jean, ed. The Nutrition Superbook: The Antioxidants. New Canaan, Conn.: Keats Publishing, Inc., 1995.

COPYRIGHT 1996 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved. 

COPYRIGHT 2004 Gale Group

http://findarticles.com/p/articles/mi_m0FKA/is_n8_v58/ai_18549482/pg_2/?tag=content;col1

Monday, June 28, 2010

CoQ10 and Being Beautiful


Two Things You Need To Be Beautiful

You simply need an effective way to keep water in your cells and get more of the nutrients you need.

Here at my clinic, I use a rejuvenating formula that restores youthful skin, without the chemicals that pollute your skin.

Here’s how it works:

Step 1 is protecting your skin from the sun, pollution, free radicals, and the destructive effects of aging. 

When you were younger, it was much easier. Your skin had a natural resilience that kept you looking your best.

There are nutrients in your skin that protect cells from damage. One of the best is CoQ10. Turns out it’s not just good for heart health. You can use CoQ10 on your skin for a beautiful complexion.

CoQ10 helps your face look younger by restoring youthful energy levels inside the cell, and protecting against future damage.

In one study titled, “The Importance of CoQ10 for Anti-Aging Skin Care,” researchers showed how CoQ10 keeps older cells functioning more like younger cells. Their discovery was published in the medical journal Biofactors.1

Having younger cells means you look younger. But when your face isn’t protected, you start looking old before your time.

The sun, pollution, a poor diet, and other toxins in your environment attack your face in the form of “oxidative stress,” or “free radical attack.” Free radicals are electrons that break away and attack healthy cells.

And here’s the thing…

Free radicals hit each cell in your face 10,000 times a day. Now multiply that by the billions of cells in your face, and you can imagine what you’re up against.

Apply CoQ10, and the cells in your skin stay younger longer.

Cell line studies support it. A team of researchers in Japan found CoQ10 protected skin cells from death caused by oxidative stress.2

That means you have an effective way to look more vibrant and prevent future damage. It all boils down to giving your face the nutrients it needs to stay looking young.

But there’s more to CoQ10… it helps reduce the appearance of wrinkles, too.

Another team of scientists discovered CoQ10 decreases the appearance of wrinkle depth. So, instead of deep grooves in your face, CoQ10 helps make those wrinkles appear shallow and less noticeable.

Step 2 for younger, more beautiful skin is water.

When your skin cells have enough water, they hold their shape. That means your skin feels taut and elastic.

The key is water… or more importantly, the nutrient that helps attract and retain water.

Feel this for yourself.

Source: www.alsearsmd.com/two-things-you-need-to-be-beautiful

Monday, June 21, 2010

Reviving up Male Fertility with CoQ10

Couples who haven’t conceived after trying for at least one year of regular, unprotected intercourse often start on a roller coaster ride of fertility therapy. The infertility process usually starts by focusing on the woman. But John E. Gould, M.D., Ph.D.—a urologist and male infertility specialist at the Northern California Fertility Medical Center in Sacramento—believes it‘s simpler to determine if the man’s sperm are healthy, before spending an inordinate amount of time checking out a woman’s fertility issues.

Sperm are highly sensitive to oxidative stress from free radicals, which can result in DNA damage and loss of motility (movement). “Male factor” infertility can account for more than 50% of the problems, says Gould.

             "The good news is that several new studies suggest that the antioxidant 
              co-enzyme Q10 (CoQ10) may help improve the odds for men with less
              -than-healthy sperm impregnating their partners."

CoQ10 is present in seminal fluid and its concentration has a direct impact on sperm count and motility. The effect of CoQ10 on sperm motility and function had been addressed only through in vitro experiments until a group of Italian researchers did two studies on infertile men. CoQ10 increased significantly both in seminal plasma and sperm cells after treatment, as well as spermatozoa motility.

Patients with lower CoQ10 levels and lower motility had a stronger response to the treatment, leading researchers to conclude that CoQ10 supplements help increase CoQ10 levels in semen and improve sperm motility in infertile men.

Researchers at Shahid Beheshti University in Tehran, Iran, recruited 212 infertile men and randomly assigned them to receive a daily CoQ10 supplement or placebo for 26 weeks. This was followed by 30 weeks with no intervention.

The study, which appears in the current issue of Journal of Urology (July 2009), found that there was significant improvement in sperm counts, density and motility in infertile men, after they took 300 mg of CoQ10 for 56 weeks.

Author Mohammad Reza Safarinejad wrote that the statistically significant but modest results of the study suggest that CoQ10 may have “potential clinical applications in infertile men.” The researcher called for further studies to evaluate if CoQ10 supplementation may play a role in achieving pregnancy in infertile couples.
In a recent study at the Polytechnic University of Marche, Ancona, Italy, 60 infertile men between the ages of 27 and 39 were given a daily dose of 200 mg of CoQ10 or placebo for 6 months, with a 3-month follow-up. CoQ10 increased significantly in both seminal plasma and sperm cells after treatment. It also improved sperm motility.

Conclusion

CoQ10 has a proven track record of supporting heart health. Now, men with fertility issues can also feel confident that CoQ10 supplementation can help support their chances of having a child.